Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Great. Good morning, everyone. Welcome. I'm Jess Fye. I'm a large cap biotech analyst at JPMorgan, and we're delighted to be continuing the conference this morning with Vertex. There's going to be a Q&A session right in this room after the company's presentation, so no need to switch rooms. There's going to be mic runners. So if you have a question, you want to raise your hand, you can do that. Alternatively, you can use the portal to fire me questions to an iPad up here, and I can ask them for you or you can just listen to my questions. But without any further ado, let me pass it over to the CEO of Vertex, Reshma Kewalramani, for the presentation.
Well, good morning, everybody. Jess, thank you so much, and thank you to JPMorgan for hosting this. It is nice to be back in San Francisco in person and to do this live. Some housekeeping notes to start with. This slide has our safe harbor statement
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
